Ohcanbohtosat - Sara A. Byron
- Čájehuvvo 1 - 16 / 16
-
1
XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts Dahkki Nicole Doudican, Sara A. Byron, Pamela M. Pollock, Seth J. Orlow
Almmustuhtton 2012Artigo -
2
Insulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells Dahkki Sara A. Byron, Kathryn B. Horwitz, Jennifer K. Richer, Carol A. Lange, Xihong Zhang, Douglas Yee
Almmustuhtton 2006Artigo -
3
-
4
FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features Dahkki Sara A. Byron, Michael G. Gartside, Matthew A. Powell, Candice L. Wellens, Feng Gao, David G. Mutch, Paul J. Goodfellow, Pamela M. Pollock
Almmustuhtton 2012Artigo -
5
Inhibition of Activated Fibroblast Growth Factor Receptor 2 in Endometrial Cancer Cells Induces Cell Death Despite PTEN Abrogation Dahkki Sara A. Byron, Michael G. Gartside, Candice L. Wellens, Mary A. Mallon, Jack B. Keenan, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock
Almmustuhtton 2008Artigo -
6
Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis Dahkki Nazlı Dizman, Yung Lyou, Nicholas Salgia, Paulo Gustavo Bergerot, Joann Hsu, Daniel Enríquez, Tyler Izatt, Jeffrey M. Trent, Sara A. Byron, Sumanta K. Pal
Almmustuhtton 2020Artigo -
7
The N550K/H Mutations in FGFR2 Confer Differential Resistance to PD173074, Dovitinib, and Ponatinib ATP-Competitive Inhibitors Dahkki Sara A. Byron, Huaibin Chen, Andreas Wortmann, David Loch, Michael G. Gartside, Farhad Dehkhoda, Steven P. Blais, Thomas A. Neubert, Moosa Mohammadi, Pamela M. Pollock
Almmustuhtton 2013Artigo -
8
FGFR2 mutations are associated with poor outcomes in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study Dahkki Y. Jeske, Shamshad Ali, Sara A. Byron, Feng Gao, Robert S. Mannel, Rahel Ghebre, Paul DiSilvestro, Shashikant Lele, Michael L. Pearl, Amy P. Schmidt, Heather A. Lankes, Nilsa C. Ramirez, Golnar Rasty, Matthew A. Powell, Paul J. Goodfellow, Pamela M. Pollock
Almmustuhtton 2017Artigo -
9
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma Dahkki Michael G. Gartside, Huaibin Chen, Omar A. Ibrahimi, Sara A. Byron, Amy V. Curtis, Candice L. Wellens, Ana Bengston, Laura M. Yudt, Anna V. Eliseenkova, Jinghong Ma, John A. Curtin, Pilar Hyder, Ursula L. Harper, Erica L. Riedesel, Graham J. Mann, Jeffrey M. Trent, Boris C. Bastian, Paul S. Meltzer, Moosa Mohammadi, Pamela M. Pollock
Almmustuhtton 2009Artigo -
10
Toward precision medicine in glioblastoma: the promise and the challenges Dahkki Michael D. Prados, Sara A. Byron, Nhan L. Tran, Joanna J. Phillips, Annette M. Molinaro, Keith L. Ligon, Patrick Y. Wen, John G. Kuhn, Ingo K. Mellinghoff, John de Groot, Howard Colman, Timothy F. Cloughesy, Susan M. Chang, Timothy C. Ryken, Waibhav Tembe, Jeffrey Kiefer, Michael E. Berens, David W. Craig, John D. Carpten, Jeffrey M. Trent
Almmustuhtton 2015Revisão -
11
Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer Dahkki Mariaelena Pierobon, Corinne Ramos, Shukmei Wong, K. Alex Hodge, Jessica Aldrich, Sara A. Byron, Stephen P. Anthony, Nicholas J. Robert, Donald W. Northfelt, Mohammad Jahanzeb, Linda Vocila, Julia Wulfkuhle, Guido Gambara, Rosa I. Gallagher, Bryant Dunetz, Nicholas N Hoke, Ting Dong, David W. Craig, Massimo Cristofanilli, Brian Leyland‐Jones, Lance A. Liotta, Joyce O’Shaughnessy, John D. Carpten, Emanuel F. Petricoin
Almmustuhtton 2017Artigo -
12
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer Dahkki Karan K. Budhraja, Bradon R. McDonald, Michelle D. Stephens, Tania Contente‐Cuomo, Havell Markus, Maria Farooq, Patricia Filippsen Favaro, Sydney Connor, Sara A. Byron, Jan B. Egan, Brenda Ernst, Timothy K. McDaniel, Aleksandar Sekulić, Nhan L. Tran, Michael D. Prados, Mitesh J. Borad, Michael E. Berens, Barbara A. Pockaj, Patricia LoRusso, Alan H. Bryce, Jeffrey M. Trent, Muhammed Murtaza
Almmustuhtton 2023Artigo -
13
Upfront Biology-Guided Therapy in Diffuse Intrinsic Pontine Glioma: Therapeutic, Molecular, and Biomarker Outcomes from PNOC003 Dahkki Cassie Kline, Payal Jain, Lindsay Kilburn, Erin R. Bonner, Nalin Gupta, John R. Crawford, Anu Banerjee, Roger J. Packer, Javier Villanueva-Meyer, Tracy Luks, Yalan Zhang, Madhuri Kambhampati, Jie Zhang, Sridevi Yadavilli, Bo Zhang, Krutika S. Gaonkar, Jo Lynne Rokita, Adam Kraya, John G. Kuhn, Winnie S. Liang, Sara A. Byron, Michael E. Berens, Annette M. Molinaro, Michael D. Prados, Adam Resnick, Sebastian M. Waszak, Javad Nazarian, Sabine Mueller
Almmustuhtton 2022Artigo -
14
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive Glioblastoma Dahkki Sara A. Byron, Nhan L. Tran, Rebecca F. Halperin, Joanna J. Phillips, John G. Kuhn, John F. de Groot, Howard Colman, Keith L. Ligon, Patrick Y. Wen, Timothy F. Cloughesy, Ingo K. Mellinghoff, Nicholas Butowski, Jennie Taylor, Jennifer Clarke, Susan M. Chang, Mitchel S. Berger, Annette M. Molinaro, Gerald M. Maggiora, Sen Peng, Sara Nasser, Winnie S. Liang, Jeffrey M. Trent, Michael E. Berens, John D. Carpten, David W. Craig, Michael D. Prados
Almmustuhtton 2017Artigo -
15
A pilot precision medicine trial for children with diffuse intrinsic pontine glioma—PNOC003: A report from the Pacific Pediatric Neuro‐Oncology Consortium Dahkki Sabine Mueller, Payal Jain, Winnie S. Liang, Lindsay Kilburn, Cassie Kline, Nalin Gupta, Eshini Panditharatna, Suresh N. Magge, Bo Zhang, Yuankun Zhu, John R. Crawford, Anu Banerjee, Kellie J. Nazemi, Roger J. Packer, Claudia Petritsch, Nathalène Truffaux, Alison Roos, Sara Nasser, Joanna J. Phillips, David A. Solomon, Annette M. Molinaro, Angela J. Waanders, Sara A. Byron, Michael E. Berens, John G. Kuhn, Javad Nazarian, Michael D. Prados, Adam Resnick
Almmustuhtton 2019Artigo -
16
Comparative Tumor RNA Sequencing Analysis for Difficult-to-Treat Pediatric and Young Adult Patients With Cancer Dahkki Olena M. Vaske, Isabel Bjork, Sofie R. Salama, Holly C. Beale, Avanthi Tayi Shah, Lauren Sanders, Jacob Pfeil, Du Linh Lam, Katrina Learned, Ann Durbin, Ellen T. Kephart, Robert Currie, Yulia Newton, Teresa Swatloski, Duncan C. McColl, John Vivian, Jingchun Zhu, Alex G. Lee, Stanley G. Leung, Aviv Spillinger, Heng-Yi Liu, Winnie S. Liang, Sara A. Byron, Michael E. Berens, Adam Resnick, Norman J. Lacayo, Sheri L. Spunt, Arun Rangaswami, Van Huynh, Lilibeth Torno, Ashley Plant, Ivan I. Kirov, Keri B. Zabokrtsky, Shahrad R. Rassekh, Rebecca Deyell, Janessa Laskin, Marco A. Marra, Leonard S. Sender, Sabine Mueller, E. Alejandro Sweet‐Cordero, Theodore C. Goldstein, David Haussler
Almmustuhtton 2019Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Biology
Genetics
Cancer
Cancer research
Gene
Internal medicine
Medicine
Oncology
Mutation
Biochemistry
Computational biology
Genome
Receptor
Bioinformatics
Clinical trial
Cohort
Endometrial cancer
Glioma
Paleontology
Pathology
Signal transduction
Cell biology
Cell growth
Colorectal cancer
Confidence interval
Dasatinib
Fibroblast growth factor
Fibroblast growth factor receptor 2
Gene expression
Genomics